Kingston Hospital NHS Foundation Trust. Finance Report February 2016 (Month 11)

Size: px
Start display at page:

Download "Kingston Hospital NHS Foundation Trust. Finance Report February 2016 (Month 11)"

Transcription

1 Enc G Original ' s Var 's Kingston Hospital NHS Foundation Trust Finance Report February 6 (Month ) A revised annual plan of a 6.m deficit was submitted to Monitor in September. The analysis in this report is shown against this revised plan. For reference, the original budget is shown on page 4.

2 CONTENTS EXECUTIVE SUMMARY SECTION : OVERALL INCOME AND EXPENDITURE SECTION : DIVISIONAL POSITIONS SECTION 3: COST IMPROVEMENT PROGRAMME SECTION 4: INCOME SECTION 5: PAY COSTS SECTION 6: NON PAY COSTS SECTION 7: STATEMENT OF FINANCIAL POSITION SECTION 8: CASH FLOW STATMENT SECTION 9: DEBTORS SECTION : CREDITORS SECTION : CAPITAL SECTION : FINANCIAL SUSTAINABILITY RISK RATING (FSRR) Appendix - INCOME DETAIL Appendix - ACTIVITY DETAIL Appendix 3 - INCOME PENALTIES Contents

3 EXECUTIVE SUMMARY Headline Trend against Trend against Narrative (January) (February) At the end of M the Trust reported a year to date deficit of 6.5m, which is.7m adverse to the revised plan submitted to Monitor. The Trust reported an in month deficit of.4m. The underlying positive variance on patient care income is.m after removing the impact of high cost drugs (.m). Other income has improved in month due to additional LDA and research income. There is also nonrecurrent benefits from the release of GRNI and income risk reserves, together totalling.7m. The underlying clinical income favourable variance was.m of the reported.3m patient care income variance (.m of the reported position related to high cost drugs). The in-month income is above forecast by.3m which includes the benefit of.m of high cost drugs,which is a pass through cost. Pay and Non Pay Expenditure directly associated with the delivery of clinical services is over forecast by.m in M. Pay is.5m adverse in month while Non Pay is overspent by.5m. High agency usage due to escalations, specials and winter pressures are driving the pay increase. Non Pay variances are partly due to high cost drugs (.m) and partly to small clinical supplies overspends across a large number of service lines. Corporate Services pay and non pay were.m better than forecast in M The main driver for this is a reduction in agency usage compared to forecast CIP Delivery stands at 83% YTD and 88% in month. The CIP programme shortfall remains mainly due to Emergency service lines where only 56% of CIPs have been achieved YTD. All other divisions are forecasting over 9% achievement. The Trust is forecasting a deficit of 6.9m. This is.5m higher than the forecast presented to Monitor since Month 8. This movement is mainly due to the junior doctor strikes reducing activity and incurring additional costs. At the end of M, capital expenditure is below forecast. Capital YTD expenditure is 87% of the revised plan. Equipment and IT delays contribute to the slippage on capital, we expect this underspend to continue to 3st March 6 The cash balance reported at the end of M was.6m. The closing cash position for January was.6m which was a deterioration of.3m on the previous month's position. At the time of producing the report the cash balance was.6m. Pg3

4 m SECTION : OVERALL INCOME AND EXPENDITURE Version Summary as at the end of Feb-6 IN MONTH YEAR TO DATE Income & Expenditure v Actuals v Actuals Original 's plan 's Actual 's Var 's plan 's Actual 's Var 's Income Patient Care Income Other Income 3,36 4,56 4,63 4,74 Income 7,83 9,347 8,75 9, ,786,66,876 6,84,9 7,33, ,954,83 88,9 4,47,36,64 Expenditure Pay Non Pay (43,6) (77,64) (46,69) (73,549) (,79) (5,937) (,43) (5,899) (5) 38 (34,4) (67,549) (35,45) (7,5) (,9) (,566) Expenditure (,646) (,39) (8,6) (8,33) (4) (,97) (5,566) (3,595) EBITDA 7,76 9, ,85 7,96 (79) Depreciation and Amortisation Investment Revenue Finance Costs Public Dividend Capital (9,394) 6 (3,4) (3,3) (8,65) 4 (3,347) (3,8) Total I&E (8,845) (6,68) (746) (43) 35 (5,85) (6,53) (67) (7) (75) (69) (74) (75) (68) (39) () (7,658) (3,7) (,959) (7,59) (3,54) (,894) 66 () (83) 65 Original Actual Actual YTD EBITDA Margin EBITDA Achieved I&E Surplus Margin 3.%.% -3.9% 4.%.% -.6%.7%.% -4.% 4.4% 7.7% -.% 3.7%.% -.8% 3.3% 9.8% -3.%. Cumulative Position Against 5/6. Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Actuals 4/5 Actuals 5/6 Original 5/6 Forecast 5/6 \\lares\finance.grp\secure Department Folders\ning\5\Reporting\Monthly Position\M\M Finance Report V8 Pg4

5 SECTION : DIVISIONAL POSITIONS Overview Summary as at the end of Feb-6 Income & Expenditure 's (4,69) 4,698 5,496 v Actuals plan Actual Var 's 's 's IN MONTH Variances Inc Pay Non Pay Total v Actuals plan Actual Var 's 's 's YEAR TO DATE Variances Non Inc Pay Pay Total Clinical Support Services (,87) (,) (35) 8 (68) (85) (35) (,596) (3,78) (,) 74 (67) (769) (,) Emergency Care,4 46 (79) (9) (38) (9) (79) 3,343,559 (,784) (6) (,3) (,47) (,784) Specialist Services 4,4 3,88 (33) (9) (97) (6) (33) 46,84 45,8 (,5) (365) (5) (,6) (,5) Clinical Divisions 4,53 3,78,3 (,75) () (546) (5) (,75) 37,55 3,3 (5,48) (36) (,9) (3,) (5,48) Commercial Director Corporate Affairs Finance Human Resources Medical Director Nursing Director Operations (,7) (3,396) (4,) (,883) (45) (,75) (6,4) (77) (9) (34) (67) (5) (4) (,68) (4) (36) (79) (69) (53) (54) (,9) (3) () () (3) (4) () (9) 4 (6) (9) 4 (8) 6 (3) (7) (3) () () (,93) (3,5) (3,96) (,73) (376) (,94) (3,86) (,89) (,777) (3,97) (,79) (3) (,43) (3,3) 4 37 () (6) 66 (3) 658 () (53) (37) (7) (34) (433) (59) 4 37 () (6) 66 (3) 658 Directorates (4,3) (3,397) (3,) 76 (9) 377 (9) 76 (36,86) (35,933) (6) 98 Central Income Other Central Budgets 7, , ,53 3, , , ,945 EBITDA 9, (5) ,85 7,96 (79),876 (,9) (,566) (79) Depreciation & Losses Interest PDC (8,65) (3,33) (3,8) (7) (73) (69) (74) (74) (68) (39) () (39) () (7,658) (3,5) (,959) (7,594) (3,34) (,894) 63 (85) (85) 65 Total I&E (6,68) (746) (43) (5,85) (6,56) (675) (675) COMMENTARY Income has underperformed in month in Respiratory, T&O, AAU and Specialist outpatients mainly as a result of lower non elective activity. However this is offset by improved income on A&E, Gynaecology, General Surgery and Cardiology. Pay has been overspent within nursing due to escalations and winter pressures being funded through agency. Specials and locum usage in medical has also contributed to this overspend. Non Pay has been overspent in month due laboratory equipment in Pathology, Laproscopic consumables in Anaesthetics and additional consumable usage in A&E due to additional activity. Income in corporate areas has improved in both pay and non pay due partly to a faster reduction in agency spend than had been forecast. Central Income and Central Budgets includes additional LDA and NMET income recieved in monthof.m. It also includes the.5m release of GRNI accruals posted into the I&E as per the recovery plan. The income risk was also reassessed in month given the lower levels of activity and.3m was released into the position form central budgets. Both of these were unplanned resulting in a variance. Pg5

6 SECTION : DIVISIONAL POSITIONS Clinical Support Services Summary as at the end of Income & Expenditure Original 's Patient Care Activities Other 5,36 Feb-6 's 8,5 5,568 IN MONTH YEAR TO DATE IN MONTH YEAR TO DATE v Actuals v Actuals Service Lines plan v Actuals v Actuals plan Actual Var plan Actual Var plan Actual plan Actual 's 's 's 's 's 's 's 's 's Var 's 's 's Var 's, , () 6,93 5, 6,648 5,739 Income 5,36 4,69,89,9 8,3, Expenditure - Pay Medical & Dental Nursing & Midwifery Scientific,Professional & Tech Admin & Clerical Other (9,757) (7,977) (3,99) (,54) (9,9) (9,857) (7,834) (4,7) (,55) (9,43) (84) (653) (334) (6) (764) (84) (74) (343) () (75) (7) (5) (9) 6 3 (9,44) (7,8) (3,66) (,47) (8,86) (9,) (7,57) (3,737) (,46) (8,378) (55) 59 (77) (346) (77) (35) (9) Anaesthetics, Theatre and DSU Histopathology Imaging Intensive Care Unit Pathology Pharmacy Sterile Services Department Therapies (3,335) (,4) (9,388) (4,945) (,65) (,58) (,545) (4,9) (,) (89) (769) (47) (8) () (9) (36) (,3) () (8) (486) (853) (95) (9) (344) (3) (3) (33) (69) (5) 6 7 (,35) (,53) (8,69) (4,58) (9,83) (,94) (,45) (3,75) (,449) (,96) (8,84) (4,846) (,339) (,35) (,358) (3,84) (4) (44) () (37) (56) (58) 58 (73) (48,76) (3,979) (4,3) (5) (44,79) (46,5) (,396) Pay (3,75) (3,34) (,69) (,758) (68) (9,597) (3,4) (67) Service Lines In Month Variances Expenditure - Non Pay Inc Pay Non Pay YTD Variances Inc Pay Non Pay Clinical Supplies & Services Other Non Pay (3,64) (,838) (6,) (3,457) (3,) (6,457) (,58) (3) (,89) (,8) (55) (,373) (6) (4) (85) (,4) (,7) (5,) (,798) (3,84) (5,88) (398) (37) (769) Anaesthetics, Theatre and DSU Histopathology Imaging Intensive Care Unit 7 (9) (53) 4 3 (3) (63) (3) (5) (3) (6) 76 (47) (88) (55) (4) (84) (37) (73) (56) (38) (8) Expenditure (48,77) (48,76) (3,979) (4,3) (5) (44,79) (46,5) (,396) Pathology Pharmacy Sterile Services Department (8) 7 () (4) () (6) (4) 4 69 () (7) 45 (5) (354) (3) 63 Therapies 6 (9) 9 (46) (7) Income Less Direct Costs (4,97) (4,69) (,87) (,) (35) (,596) (3,78) (,) 8 (68) (85) 74 (67) (769) Income & Expenditure Commentary The month position is 35k adverse against the revised plan. Patient Care Income is 3k better than forecast and this is driven by the continued increase in activity in ICU in month which has resulted in an overperformance in income against forecast,. The acuity of patients and therefore the tariff received is still lower than had been planned (organ, and 3 supported),likely due to the success of the inreach and 4/7 sepsis initiatives. Other Income is k adverse against the plan in month driven by an adjustment to the invoices to Surbiton Hospital and Surbiton Health Centre as part of the Your Healthcare service contract. Pay is 68k adverse against the revised plan and this is mainly ICU, Radiographers and Radiologists and Pathology. In Imaging additional premium agency costs have been incurred due to the Gynae and thyroid lists being moved to theweekend and out of hours working to accommodate the breast work. Recruitment is underway to recruit permanently into the vacant consultant posts. In Pathology agency costs relating to chemical pathology are driving the adverse variance against forecast but these are chargeable to SWL Pathology and are reflected in other income. In ICU, agency usage to cover 9 wte vacancies is driving the overspend. Non Pay is 85k adverse against the revised plan. The adverse position largely lies within Pathology and Anaesthetics. The overspend in Pathology relates to lab equipment in chemical pathology and the SWL Pathology contract. These are chargeable to SWL Pathology and are reflected in other income. In Anaesthetics the overspend is due to laparoscopic consumables, wound closures, respiratory tubes and masks and medical and surgical equipment. CIP Commentary In month, the division achieved 83k (95%) of its target. The main shortfall relates to ceasing the Radiology SLA with St Georges for junior Doctors ( 63k YTD) Divisional Actions Actions were agreed within ICU, imaging and theatres to include: s to address recruitment to reduce agency spend Reviewing data on consultant productivity with action plans produced Review non pay spend within Imaging and understand the increase in the charge on the managed service contract. Develop plan to ring-fence slots for GPs Develop plan with theatres to ensure capacity available and wastage minimised Outsource out of hours reporting to expand in house capacity for routine work. Agree job plans for Imaging consultants and recruit into 3 vacant posts which will reduce agency usage from July 6 Pg6

7 SECTION : DIVISIONAL POSITIONS Emergency Care Summary as at the end of Income & Expenditure Patient Care Activities Original 's Other,347 Feb-6 plan 's 58,867,43 IN MONTH YEAR TO DATE IN MONTH YEAR TO DATE v Actuals v Actuals plan v Actuals v Actuals Service Lines plan Actual plan Actual Var plan Actual plan Actual 's 's Var 's 's 's 's 's 's 's Var 's 's 's Var 's Income,347 6,8 4,89 4,7 (9) 55,6 55, (6) Expenditure - Pay Medical & Dental Nursing & Midwifery Scientific,Professional & Tech Admin & Clerical Other (,557) (8,63) (8) (,38) (33) (,79) (,344) (89) (,9) (633) 4, (,54) (,68) (64) (8) (4) 4,75 (3) (,59) (,974) (68) (9) (46) 6 (4) (5) (356) (4) () (5) 53,897,39 53,93,7 34 (6) Accident and Emergency Acute Assessment Unit Cardiology Elderly Care Gastro and Endoscopy (44) Respiratory (75) Site management Pay (3,666) (36,56) (,959) (3,34) (38) (33,3) (34,55) (,3) Service Lines In Month Variances Expenditure - Non Pay Clinical Supplies & Services Other (3,3) (6,457) (,836) (6,59) (33) (54) (,5) (8,73) (746) (,9) (59) (,566) (9,48) Non Pay (9,479) (9,47) (746) (965) (9) (8,68) (9,97) (,47) Expenditure (4,45) (45,583) (3,75) (4,35) (6) (4,883) (44,44) (,558) (37) (648) (85) (34) (,64) (6,76) (789) (,9) (658) (3,5) (6,9) (43) () (66) (4) (85) Accident and Emergency Acute Assessment Unit Cardiology Elderly Care Gastro and Endoscopy Respiratory (9,73) (5,356) (8,9) (3,) (5,75) (3,39) (,59) (785) (4) (66) (,8) (4) (6) (87) (83) (5) (789) (,34) (494) (99) (87) (38) (89) (9) (3) (8) (39) (8,938) (4,934) (7,569) (,97) (4,663) (,879) (973) (9,735) (5,38) (8,4) (,346) (5,63) (,947) (989) (796) (4) (555) (49) (5) (45,583) (3,75) (4,35) (6) (4,883) (44,44) (,558) Inc Pay Non Pay 43 (64) (5) () (43) () (8) (8) (95) (56) (3) YTD Variances (67) (7) Inc Pay Non Pay Site management (3) () () 6 (3) Income Less Direct Costs (4,798) 4,698,4 46 (79) 3,343,559 (,784) (9) (38) (9) (6) (,3) (,47) (37) (9) () (8) (5) (8) 358 (6) 48 (34) (49) (3) (549) (78) 55 (367) (7) () (48) (7) (6) (5) (3) (58) Income & Expenditure Commentary The month position is 79k adverse against the revised plan. Patient Care Income is 6k better than the revised plan. A&E activity has been higher than forecast but this is offset by an underperformance in non elective income. Other income is 4k adverse and this is in elderly care where the commissioners will not be paying for the Geriatritian of the day service. (GOD Service) Pay is 38k adverse against plan. This is mainly within the nursing staff group. where escalations and winter pressures including Claremont have been funded through agency. Specials usage in Hardy ward along with the locum usage in medical staffing in Gastro is driving the pay overspend. Non pay is 9k adverse against the revised plan. This is partly due to high cost drugs ( 7k) which are offset by income within Cardiology. In A&E,the overspend is due to purchase of medical & surgical supplies reflecting higher activity. CIP Commentary The Emergency Services Division achieved 36% of its CIP target in month. Underachieving CIPs Sleep Apnoea ED Case mix / over-performance EDOU closure resulted in the loss of CIP's associated with it. Divisional Actions All ECIST steps are being factored into the transformation plan to minimise 4 hour breeches going forward. Pursue with recruiting into the consultant vacancies within the Gastro/Endo specialities Recruitment to vacant medical posts in progress. with success in the DD and CoE role will continue with locums in CoE, Stroke and ACPs while we continue to recruit. Matrons to lead on reducing the Specials expenditure through better management of substantive HCA establishment and improved assessment of patients. Discharge project will be working to reduce LoS along with employment of Locum CoE consultant against current vacancy. Working to ring fence AAU trollies to increase ambulatory care activity has not yet been successful Pg7

8 SECTION : DIVISIONAL POSITIONS Specialist Services Summary as at the end of Feb-6 Income & Expenditure Income Patient Care Activities Other Original 's,37 4,944 's 5,4 5,47 IN MONTH v Actuals plan Actual Var 's 's 's,38 49,8 553 (7) 44 YEAR TO DATE v Actuals plan Actual Var 's 's 's 4,474 4,648 3,76 5,3 Income 7,8 3,466,79,76 (9) 9, 8,757 (365) Expenditure - Pay Medical & Dental Nursing & Midwifery Scientific,Professional & Tech Admin & Clerical Other (,3) (5,35) (,63) (5,5) (,54) (,487) (5,55) (,597) (5,45) (,7) (,694) (,69) (4) (463) (95) (,796) (,8) (4) (43) () () (39) 49 (6) (8,793) (,9) (,457) (4,988) (,77) (9,445) (,593) (,46) (4,85) (,9) Pay (53,73) (53,76) (4,56) (4,659) (97) (49,5) (49,367) (5) Expenditure - Non Pay Clinical Supplies & Services Other (7,686) (6,6) (7,66) (7,593) (637) (,45) (77) (,54) (33) (7) (6,969) (6,34) (7,349) (6,759) Non Pay (3,947) (5,9) (,88) (,94) (6) (3,3) (4,8) (,6) Expenditure (77,67) (78,97) (6,649) (6,953) (33) (7,38) (73,476) (,57) Income Less Direct Costs 49,5 5,496 4,4 3,88 (33) 46,84 45,8 (,5) (748) 384 (65) (3) (38) (65) Service Lines GUM Gynaecology and Breast Maternity Ophthalmology Oral and ENT Paediatrics and NNU Specialist Outpatients plan 's (3,749) (5,8) (9,58) (7,75) (4,66) (,37) (,97) IN MONTH v Actuals plan Actual 's 's Var 's (3) (496) (,595) (638) (34) (89) (854) (346) (54) (,567) (7) (35) (97) (86) (5) (8) 8 (84) (9) (7) (7) YEAR TO DATE v Actuals plan Actual 's 's Var 's (3,48) (5,35) (7,563) (7,4) (3,75) (9,347) (9,43) (3,4) (5,5) (7,34) (7,457) (3,778) (9,39) (9,58) (344) (53) (43) (64) Total Specialist Services (6,878) (5,35) (5,68) (33) (55,76) (56,8) (357) General Surgery and Urology Trauma and Orthopaedics (8,658) (9,433) (75) (8) (833) (85) (8) (4) (7,969) (8,63) (8,5) (8,883) (54) (6) Total (78,97) (6,649) (6,953) (33) (7,38) (73,476) (,57) Service Lines GUM Gynaecology and Breast Maternity Ophthalmology Oral and ENT Paediatrics and NNU Specialist Outpatients In Month Variances Inc Pay Non Pay (6) (46) (9) 7 (8) (33) 3 (38) () (8) (5) YTD Variances Inc Pay Non Pay 48 5 () () 7 () 53 (3) (64) 66 (33) (7) (3) (37) Total Specialist Services 6 (5) (9) (644) General Surgery and Urology Trauma and Orthopaedics 6 (5) (8) () (47) (3) (3) (,7) (366) (73) (74) (87) Total (9) (97) (6) -365 (5) (,6) Income & Expenditure Commentary The month position is 33k adverse against the revised plan. Patient Care Income is 7k adverse against forecast. This is mainly within Trauma and Orthopaedics. Pay is 97k adverse against the revised plan. The overspend is mainly within medical staffing with agency usage in Paediatrics due to the shortage in middle grades. and in Ophthalmology. Non Pay is 6k adverse against the revised plan. 56k of this relates to clinical supplies mainly within Gynaecology, Surgery, Ophthalmology and Trauma and Orthopaedics. The purchases are activity driven and there is also an overspend in GUM relating to drugs within tariff. CIP Commentary The division has achieved.m of its target in month (87%). Schemes not delivering in month mainly relate to: T&O - coding of outpatient with procedures and non pay savings. Although procedure coding is being undertaken by the service this does not secure additional funding. Investigations are being undertaken between the coding, service and commissioning teams to understand this. Divisional Actions Understanding from the partnership board /Epsom Orthopaedics Centre the recovery of the current SWELOC position. A review of process in Gynaecology to ensure maximum utilisation of theatres and DSU has been undertaken. Consultants are signing off theatre lists now and this will drive better utilisation of theatres. DNA's are high in Gynae & Breast and the ser vice have developed an action plan to address the underlying causes. The service management are working collaboratively with theatres to address and resolve some of the under utilisation of theatres. Benefit of this is expected to be seen from March onwards. Job plans for Orthopaedics is being reviewed and will be undertaken by the new CD. Pg8

9 SECTION : DIVISIONAL POSITIONS Corporate Summary as at the end of Income & Expenditure Feb-6 IN MONTH YEAR TO DATE FORECAST OUTTURN IN MONTH YEAR TO DATE Original v Actuals v Actuals Budget v Forecast Service Lines v Actuals v Actuals Variances Actual Var Actual Forecast Actual Actual 's 's 's 's 's 's 's Var 's 's 's Var 's Inc Pay Non Pay Total 's 's 's Var 's 's 's Var 's Commercial Director (,7) (77) (4) 36 (,93) (,89) 4 Patient Care Activities,8, Corporate Affairs (3,396) (9) (36) 53 (3,5) (,777) 37 Other 5,938 5, (9) 5,439 5, Finance (4,) (34) (79) 5 (3,96) (3,97) () Income 7,8 6, (9) 6,373 6, Human Resources (,883) (67) (69) 98 (,73) (,79) (6) Expenditure - Pay Medical Director (45) (5) (53) (3) (376) (3) 66 Medical & Dental (,97) (,9) (8) (9) 88 (,848) (,79) 9 Nursing Director (,75) (4) (54) () (,94) (,43) (3) Nursing & Midwifery (,369) (,9) (6) (8) 5 (,85) (,45) 4 Operations (6,4) (,68) (,9) () (3,86) (3,3) 658 Scientific,Professional & Tech (567) (487) (36) (37) () (45) (56) (66) (4,3) (3,397) (3,) 76 (36,86) (35,933) 98 Admin & Clerical (8,659) (,56) (88) (76) (9,74) (9,375) 365 Other (8,69) (8,936) (89) (655) 54 (8,8) (7,6) 58 Pay (,76) (4,93) (,49) (,67) 377 (,5) (,75) 976 Expenditure - Non Pay Clinical Supplies & Services (439) (567) (5) (49) (55) (534) (9) Other (,49) (,33) (,856) (,95) (94) (,468) (,6) (593) Non Pay (,857) (,879) (,97) (,999) (9) (,983) (,595) (6) Expenditure (44,34) (47,7) (3,955) (3,67) 85 (43,34) (4,87) 364 Income Less Direct Costs (37,6) (4,3) (3,397) (3,) 76 (36,86) (35,933) 98 Service Lines Commercial Director Corporate Affairs Finance Human Resources Medical Director Nursing Director Operations In Month Variances Inc Pay Non Pay (3) (4) () (9) 4 (6) (9) 4 (8) 6 (3) (7) YTD Variances Inc Pay Non Pay () (53) (37) (7) (34) (433) (59) (9) 377 (9) (6) Income & Expenditure Commentary The month position is 76k favourable in month against the revised plan in month. The main areas are explained below: Income is ( 9k) adverse in month against plan. This is mainly due to reduced Nursery income received in month ( 38k) Pay is 377k favourable against plan in month. This is driven by Nursing, Commercial, HR, Operations and Finance. This is driven by a rationalisation of Agency use and accruals 57k, Substantive vacancies 93k, Medical staff recharges 4k. Non pay is adverse against the revised plan by ( 9k) in month. This continues to be driven by Overseas recruitment of Nurses will continue until the end of the year ( 56k) and Clinical Equipement and IT ( 56k); Estates department postage ( 73k) due to a billing backlog; offset by Corporate Affairs and others 37k. CIP Commentary The Corporate Directorate achieved 94% of its CIP target in month and 96% YTD. Underachieving CIPs Energy Rebate negotiations for 5k rebate are ongoing. Divisional Actions Recruiting to vacant posts. Finance has almost completed its recruitment drive which is resulting in a lower agency spend. PFI variation model is being developed to forecast seasonality. Pg9

10 SECTION 3: COST IMPROVEMENT PROGRAMME Division Annual 's IN MONTH Actual Variance 's 's 's YEAR TO DATE Actual Variance 's 's 's,44 Emergency Care,338 4 (7),7 685 (54) Specialist Services, (3),67,44 (3) Clinical Support Services, (5) (6) Commercial 7 () 96 (4) Corporate Affairs () 7 7 () Finance 8 5 (5) () HR () 5 5 () Medical () Nursing Operations (9) (4) Central (CNST),4,9,9 Total CIP 8, (4) 8, 7,53 (968) Type Summary as at the end of Annual 's Feb-6 In Month Actual Variance 's 's 's YTD Actual Variance 's 's 's COMMENTARY In month achievement is 83% of plan (YTD 88%). The CIP plan is in line with prior month projections and shortfalls continue in Emergency Services and T&O. All CIP shortfalls have been included in the Trust's forecast position. In Operations, we have been successful in securing an Energy rebate with our PFI provider amounting to.m but this is not yet reflected in the position. See divisional commentaries for further details of specific schemes and actions. Cost Reduction,54 4 (6),33,65 (65) 97% 97% Income Generation 6, (7) 5,89 4,988 (9) 78% 85% Total CIP 8, (4) 8, 7,53 (968) 83% 88% Pg

11 SECTION 4: INCOME Income Risk Summary 5/6 - Table COMMENTARY I&E YTD ( 86.m) Billed ( 8.8m) Accrued ( 3.3m) Paid ( 75.3m) Unpaid ( 7.5m) Low Risk( 3.m)* Medium Risk(.m)* Table Table shows income in 5/6 position and breaks it down into how much has not been received in cash terms. The Accrued income has increased from.6m to 3.3m. This Var primarily 's relates to.3m of NCA income,.m of over performance,.3m of GUM and the rest relates to Cancer, CQUIN and OSV reciprocal patients. 4/5 IMPACT IN 5/6 - Table Year End Accrual 7.m Billed 7.m Accrued.m Paid ( 6.6m) Unpaid (.4m) Low Risk( m)* Medium Risk(.m)* *Note: the risks have been estimated by the finance department. The 7.m unpaid invoices down from 9.m in the previous mounth, relates to 6.m of SLA overperformance invoices,.8m of NCA and.3 of GUM and IVF invoices Table Table shows the position on the 4/5 yearend income accrual and breaks it down into how much has not been received in cash terms. Further details of unrecovered items are shown on page 8. Pg

12 SECTION 5: PAY COSTS Costs 's In Month Var 's Actual 's Variance 's Year to Date 's Actual 's Variance 's Medical & Dental Nursing & Midwifery AHP Scientific, Professional & Tech Directors & Managers Admin & Clerical Support Staff (44,54) (55,53) (7,9) (6,9) (,5) (9,83) (,837) (3,74) (4,645) (67) (575) (884) (,594) (55) (3,788) (5,67) (679) (588) (78) (,435) (47) (46) (4) (9) (3) (4,8) (5,899) (7,38) (6,3) (9,68) (8,35) (,68) (4,86) (5,647) (7,45) (6,457) (8,7) (7,78) (,64) (,5) (748) (67) (45) Total Pay before Central Bud (46,598) (,66) (,43) (65) (34,344) (35,45) (,7) Reserves & CIP (9) (3) 3 (78) 78 Total Pay (46,69) (,79) (,43) (5) (34,4) (35,45) (,9) COMMENTARY The in-month pay is.m adverse against the revised plan. The majority of the nursing overspend is due to high usage of agency for escalations during the month with Claremont ward remaining open. The main adverse variances are in A&E, Elderly Care and AAU. Admin & Clerical and Managers have performed better as most of the agency posts have been recruited to or discontinued. The agency caps are also having a positive impact. Pg

13 SECTION 5: PAY COSTS Temporary Staffing analysis Qualified Nursing & Midwifery Medical & Dental Admin and Estates Staff Managers Other Grand Total 's Var 's Agency Bank Managers 34-6,37 8 Total Current Month, ,37 YTD Agency 7,34 3,949,4 85, ,54 Bank 4,634,7, ,38 Total YTD,957 6,9 3,733 98, ,886 Top 5 Agency users Commentary Total agency as a proportion of pay expenditure decreased from.% to.7% in month, whilst Bank staff expenditure has increased from 6.% to 6.5% of total pay. The additional staffing required for winter escalation is managed through agency, resulting in the agency spend not decreasing significantly. Monitor's cap of % applies for Q3 and Q4 and relates to nursing agency as a percentage of total nursing pay excluding HCA's. In January this percentage is 5.6%, up from 5.% in January. Current Month Year To Date Elderly Care Accident and Emergency Trauma and Orthopaedics Paediatrics and NNU Gastro and Endoscopy Other ,436,996, ,588 Total,37 6,54 Pg3

14 SECTION 5: PAY COSTS Costs Original 5 ' s Var 's 5/6 Bank and Agency Spend Admin and Estates Staff Allied Health Professionals Managers Medical And Dental Staff Qualified Nursing & Midwifery Other Grand Total Top 5 Agency and Bank Users Current Month Elderly Care 45 Accident and Emergency 8 General Surgery and Urology 39 Gastro and Endoscopy 33 Trauma and Orthopaedics 3 Others,9 Total,37 Year To Date Elderly Care 3,555 Accident and Emergency,93 General Surgery and Urology,36 Gastro and Endoscopy,37 Trauma and Orthopaedics,4 Others 4,56 Total 4,886 Pg4

15 SECTION 6: NON-PAY Non Pay 's In Month Actual Variance 's 's 's Year to Date Actual Variance 's 's 's Clinical Supplies & Services Drugs High Cost Drugs Transport Establishment General Supplies Other Premises PFI CNST (4,499) (4,877) (,837) (,479) (,993) (,96) (,76) (7,39) (,34) (4,757) (,98) (48) (,9) (4) (88) (45) (85) (595) (,3) (396) (,6) (,387) (,9) () (63) (6) (9) (67) (,34) (397) (8) (,39) (75) 9 (4) (76) (3) () (,58) (4,477) (,79) (,345) (,8) (,689) (,575) (6,55) (,3) (4,36) (3,743) (4,65) (,866) (,3) (,875) (,95) (3,69) (6,98) (,77) (4,367) (,35) 3 (,74) 5 (73) (36) (495) (43) 34 (6) Non Pay before Central Budgets (74,596) (6,) (7,66) (,56) (68,49) (7,5) (3,9) Reserves, , Total Non Pay (73,549) (5,937) (7,9) (,54) (67,549) (7,5) (,566) COMMENTARY Non Pay is overspent by.m in month or.6m after removing the impact of pathology recharges, high cost drugs and one off GRNI releases from the balance sheet. The clinical supplies and services overspend in the clinical divisions is driven by specialties such as Gynaecology, Ophthalmology, Cardiology and General Surgery and Urology where the activity has improved. In Anaesthetics, there is a continued overspend on laparoscopic consumables and other medical and surgical equipment. Pg5

16 SECTION 7: STATEMENT OF FINANCIAL POSITION 4/5 Audited m January m February m NON CURRENT ASSETS: Property plant and equipment Intangible assets Other assets TOTAL NON CURRENT ASSETS: CURRENT ASSETS: Inventories Trade and other receivables Cash and cash equivalents TOTAL CURRENT ASSETS CURRENT LIABILITIES: Trade and other payables Current Borrowings Current Provisions (9.) (.9) (.4) (33.) (.9) (.) (3.9) (.4) (.) TOTAL CURRENT LIABILITIES (3.5) (34.) (33.4) NET CURRENT ASSETS LESS CURRENT LIABILITIES (.8) (6.6) (7.) COMMENTARY Non - Current Assets There was a.5m decrease in February, comprising.m of additions and.7m depreciation. Current Assets There was a.8m decrease in Current Assets in February 6 comprising:.7m decrease in Cash and Cash Equivalents, as analysed in Section 8: Cash Flow Statement and a.m decrease in Inventories. Current Liabilities The decrease of.8m in Current Liabilities in February was largely due to a decrease in non-nhs Accruals which is analysed further in Section. TOTAL ASSETS LESS CURRENT LIABILITIES NON CURRENT LIABILITIES: Borrowings Provisions Other liabilities (9.6) (.3) (34.8) (.4) (34.) (.4) TOTAL ASSETS EMPLOYED FINANCED BY TAXPAYERS EQUITY: Public Dividend Capital Revaluation reserve Income and Expenditure Reserve - Prior years Income and Expenditure Reserve - Current year (6.) (6.5) TOTAL TAXPAYERS EQUITY Pg6

17 SECTION 8: CASH FLOW STATEMENT January 5 m Surplus/(deficit) after tax. Non-cash flows in operating surplus/(deficit) Depreciation and amortisation.7 PDC Dividend expense.3 Non-cash flows in operating surplus/(deficit). Var 's Operating Cash flows before movements in working capital. Increase/(Decrease) in working capital (Increase) in Inventories. (Increase) in Trade and other receivables (.) (Decrease) in Current Provisions (.) (Decrease) in Trade and Other payables (.5) Increase/(Decrease) in working capital (.5) Net cash (outflow) from operating activities (.4) Net cash inflow/(outflow) from investing activities Property t and Equipment (.) Intangible assets (.) Other assets. Net cash inflow/(outflow) from investing activities (.) Net cash inflow/(outflow) from financing activities PDC Drawdowns. PDC Dividend paid. Borrowings (.) Net cash inflow/(outflow) from financing activities (.) Net (decrease) in cash (.7) COMMENTARY The closing cash position for February was.6m which was.7m below the original month 5 forecast. The shortfall in the cash position was primarily attributable to unpaid overperformance invoices from commissioners for Q and Q totalling 3.m (Kingston, Richmond and Surrey Downs CCGs). Of this amount,.m has subsequently been paid by Surrey Downs in the first week of March. The impact of these unpaid amounts was offset in the month by slowing payments to trade creditors (.6m at the end of February). Lower than expected receipts from Royal Marsden (.m) and St Georges (.3m) were compensated by higher than forecast payments from Local Government organisations for GUM services (.m) and VAT reclaimed from HMRC (.m). Opening cash.3 Closing cash.6 Pg7

18 SECTION 9: DEBTORS Breakdown of Trade and Other Receivables (SoFP) in m: Months Mar-5 Apr-5 May-5 Jun-5 Jul-5 Aug-5 Sep-5 Oct-5 Nov-5 Dec-5 Jan-6 Feb-6 Income Accruals Aged Debtors (NHS and non NHS) Prepayments (mainly maintenance) Other* (.3) (.3)..4. Total Total Debt Outstanding As at 9th February 6 Up To 3 Da 3 To 6 Days to 9 DayOver 9 DayOverall Total Feb-6 Jan-6 Dec-5 Total Total debt at 9th February 6 9,64 748,39 4,6 5,493 6% 5% 9% 7% Total debt at 3st January 6 7,4 4,6 8 5,6 6,654 43% 4% % 3% Total debt at 3st December 5 8,36 98,4 4,655 4,354 58% % 7% 3% Commentary Trade and Other Receivables have increased by.m to 3.9m, the net effect of a.m increase in Income Accruals, a.9m decrease in Prepayments and a.9m decrease in Aged Debtors (NHS and non NHS) and a.m decrease in Other Debtors. Aged debtors decreased from 6.6m to 5.7m in month. Within this total, the current (<3 day) debt increased by.m, debt from 3-6 days decreased by 3.3m, 6-9 day debt increased by.m and debt over 9 days decreased by.m. Within these categories the significant movements were:- Invoices issued to CCGs at the end of January for the cumulative freeze position at Month 8 totalling.8m remain unpaid but remain in the -3 days bucket due to the short length of February Richmond CCG paid.5m for Q & Q 5/6 overperformance reducing 3-6 days debt Merton CCG paid.m over-performance invoices reducing 3-6 days debt Payments of.3m from Barking Havering & Redbridge NHST and.3m from BMI Healthcare both reduced over 9 days debt The increase of.m in income accruals relates mainly to month 9 overperformance. The.9m decrease in Prepayments was largely due to a.4m decrease in the CNST prepayment, a.m decreasein the AAH prepayment and a.m decrease in the Business Rates prepayment *Other includes the Provision of Irrecoverable Debts, Recoverable VAT and Other Debtors all due within one year. Pg8

19 SECTION : CREDITORS Description Aug-5 Sep-5 Oct-5 Nov-5 Dec-5 Jan-6 Feb-6 NHS Accruals (.3) (.4) (.6) (.5) (3.3) (3.) (3.4) Non NHS Accruals (4.) (3.) (.8) (.6) (.6) (.) (8.8) Capital Accruals (.7) (.4) (.6) (.) (.) (.4) (.) System GRNI Accruals (.9) (3.) (3.) (.5) (.8) (6.3) (.8) Deferred Income (3.6) (.6) (4.6) (3.6) (.6) (3.8) (3.) Trade Creditors (.7) (5.9) (.9) (3.) (6.) (6.3) (6.6) Income Tax and PDC Due Within Yr (4.4) (4.5) (4.5) (4.6) (4.6) (4.6) (4.7) Others including Provisions, PFI and Finance Leases (.8) (.) (.4) (.7) (.) (.4) (.9) Total (35.4) (35.) (3.7) (3.8) (33.3) (34.) (33.4) Commentary Outstanding creditors as at 9th February totalled 33.4m, a.8m decrease in month which comprised the net effect of:.3m increase in Trade Creditors which at the end of February, of which.m relates to an increase in slowed payments to suppliers at month end..3m decrease in Non NHS Accruals largely attributable to;.7m decrease in Trade Revenue accruals -.m decrease in Medical Pay accruals,.m decrease in General Surgery, Prime Care Solutions, Dalkia and Global Services..6m decrease in accrued JAC Pharmacy invoices.7m decrease in deferred income, due largely to; -.4m decrease in Q4 Madel deferred income -.m increase in Q4 Sift deferred income -.m increase in M 5-6 Winter Funding As in January, Trade Creditors in February remain comparatively high to previous months in the year. This is the combined impact of invoices being processed more quickly onto the financial system and constraints on the funds available resulting in payments being slowed as necessary. Pg9

20 SECTION : CREDITORS (BETTER PAYMENTS PRACTICE CODE) Commentary Original 's Var 's NHS Invoices paid within 3 days The value and number of NHS invoices paid within term both decreased in month. Invoice number remains below target. This is mainly attributable to 33 NHS Supply Chain invoices being paid late, accounting for 74% of all NHS out of term invoices. The drop in the invoice value was largely due to NHS Blood & Transplant invoices totalling 95k Non NHS Invoices paid within 3 days Both the value and number of NHS invoices paid within term decreased to 3% and 3% respectively in month. The value of invoices paid ontime fell below target in February due mainly to 336 ID Medical Group invoices and 6 Roche Diagnostics invoices totalling 645k being paid out of term. Overall, the percentages remain well below the target of 95% as the Trust manages its cash resources whilst awaiting payment of overperformance invoices from NHS commissioners. Pg

21 SECTION : CAPITAL 5/6 Capital Budget YTD YTD Spend YTD Variance Annual Updated Variance to ESTATES MAINTENANCE 3,3,659, ,3,77,358 5, , ,97 5, EQUIPMENT TOTAL IT TOTAL 3,57 3,34 3,3 3,57 3,53 37 Others TOTAL CAPITAL PROGRAMME 4,49,8,4,58 4,49,75,874 COMMENTARY Cumulative to Month, the Trust spent.m. This is.6m below the Trust s updated plan capital programme of.8m. Equipment spend is below updated plan by.49m. A&E & ITU monitoring machines ( 56k) scheduled for November have not arrived yet. IMT is.m underspent. Delays in commencement of SSD Track and Trace ( 3k), Server Replacement ( 34k) and PC and Mobile Replacement ( 4k) were the main reasons for this underspend. Estates Strategy is.5m underspent at M. Outpatients is 557k behind plan. The revised costs for 5/6 are currently been reviewed but some slippage into 6/7 is expected. Estates Maintenance is underspent by.m, due to delays in the commencement of Nurse Call Esher Wing ( k) and slippage in Pipework Replacement Phase II ( 73k) and Electrical Distribution Boards ( 56k). These slippages are expected to be corrected before year end. Others relates to Nursing Tech Fund and Charity Funded capital projects. Pg

22 SECTION : FINANCIAL SUSTAINABILITY RISK RATING (FSRR) Capital Servicing Capacity Liquidity I&E Margin - Underlying performance I&E Margin - Variance from plan Weight 5% 5% 5% 5% % % % % -% % -% <.5 <-4 <=- <=- 5/6 5/6 5/6 5/6 5/6 5/6 5/6 5/6 5/6 5/6 5/6 5/6 Heading M M M3 M4 M5 M6 M7 M8 M9 M M M Capital Servicing Capacity Liquidity I&E Margin - Underlying performance I&E Margin - Variance from plan.5 (5.) (4.5%).%.7 (6.4) (4.%).%.9 (8.) (3.%).%. (4.5) (.3%).%.7 (8.9) (4.%).%.8 (.5) (3.8%) (.%). (.3) (3.%).%. (8.7) (.9%) (.3%).8 (.) (3.6%) (.6%). (.) (3.%) (.5%).5 (.7) (.6%).% /4 3/4 3/4 3/4 3/4 3/4 3/4 3/4 3/4 3/5 3/6 3/7 Heading M M M3 M4 M5 M6 M7 M8 M9 M M M Capital Service Cover Liquidity I&E Margin - Underlying performance I&E Margin - Variance from plan Weighted average FSRR Rounded Weighted average COSR Capital Servicing Capacity I&E Margin Actual Liquid ratio I&E Margin Variance From COMMENTARY Our FSRR rating for month is a. This is driven by a variance from plan of % Pg

23 Appendix : INCOME DETAIL Income Summary Income 's In Month Actual 's Var 's Year to Date Actual Variance 's 's 's Patient Care Activities - CCG RTA\OSV Private Patients Other Patient Care Income, ,3 6, , (4) () () 84, ,7 86, ,5 Total Patient Care Income 4,63 6,84 7, ,954 88,9,36 Education BMI Provider to Provider Other 8,69,4 4,84, (4) ,46,97 3,94 9,496 8,63,93 4,67,9 Total Income 9,347 8,75 9, ,786,66,876,3 (55) (36) (37) 8 7 COMMENTARY Patient care income has improved due to the reassessment of income risk. Other income shows a favourable variance as additional LDA income recieved from HESL. Pg3

24 Appendix : ACTIVITY DETAIL Patient Care Activity Activity In Month Spells / Attendances Variance Year to Date Spells / Attendances Actual Variance Elective Day Cases Non Elective Out Patients A&E Critical Care Direct Access 3,964 3,953 6,8 364,44,44 9,6,858,356 33,996,69 3,369 9, ,96 33,5,35 34,45 9, ,373 9 (34) 3, (78) (8,84),973 7,965 9,5 73,38 83,568 6,9,43,767 3,59,535 4, ,48,35 8,964,64, ,57 5,473 95,93 8,747,5 46,847 Patient Care Income Income In Month Year to Date 's 's Actual 's Var 's 's Actual 's Variance 's Elective Day Cases Non Elective Non Elective Threshold Readmissions Out Patients A&E Critical Care Direct Access High Cost Drugs Non Elective - Maternity Pathway Out Patients - Maternity Pathway Other CQUIN 8,89 9,333 5,3 (,67) 46,48,63 9,4 8,5,87,39 8,58 3, ,686 4,59 (33) 4, ,5, SLA Income,45 6,634 6, ,93 86,34,3 7,646 3,958 (3) 3,84, ,9,, (59) (4) (3) (77) 66 6 () 4 () () 7,667 47,89 (,494) 4,8,58 8,76 7,5,769,369,36,3 3,69 7,83 7,385 46,99 (,59) 4,654,999 8,65 7,3,84,4,63 6,73 3,53 7,83 (8) (9) (35) (573) 47 () (),46 (7) (63) (5,589) (5) COMMENTARY The activity performance is detailed below: Non Electives and Critical care activity are below forecast. However A&E attenders are performing above plan. Pg4

25 Appendix 3 Income Penalties April May June July August September October November December January February YTD 8 week Breaches Mixed Sex Accomodation penalty Cancer Waits Cancelled Operations MRSA Penalty A&E Breaches Ambulance handovers OP New to Follow Up DCOP Readmissions , ,59 Commentary - The above table now shows all penalties that have been incurred by the Trust. A&E breaches penalties has increased in month. All other penalties remain in line with trend.

Kingston Hospital NHS Foundation Trust. Finance Report December 2017 (Month 09)

Kingston Hospital NHS Foundation Trust. Finance Report December 2017 (Month 09) Original 0 0 0 ' s Kingston Hospital NHS Foundation Trust Finance Report December 2017 (Month 09) CONTENTS EXECUTIVE SUMMARY........3 SECTION 1: OVERALL INCOME AND EXPENDITURE.......4 SECTION 2: DIVISIONAL

More information

Kingston Hospital NHS Foundation Trust. Finance Report October 2018 (Month 07)

Kingston Hospital NHS Foundation Trust. Finance Report October 2018 (Month 07) Original 0 0 0 ' s Var Kingston Hospital NHS Foundation Trust Finance Report October 2018 (Month 07) CONTENTS EXECUTIVE SUMMARY........3 SECTION 1: OVERALL INCOME AND EXPENDITURE.......4 SECTION 2: DIVISIONAL

More information

Finance Report: 2014/15 Month 9. Maria Moore Deputy Chief Executive/Director of Finance TRUST BOARD 29 th January 2015

Finance Report: 2014/15 Month 9. Maria Moore Deputy Chief Executive/Director of Finance TRUST BOARD 29 th January 2015 Finance Report: 2014/15 Month 9 Maria Moore Deputy Chief Executive/Director of Finance TRUST BOARD 29 th January 2015 Summary as at 31 st December 2014 1. Actual YTD deficit of 4.48m 2. 5.05m variance

More information

Finance Report M4 2016/17

Finance Report M4 2016/17 Finance Report M4 2016/17 Summary The Trust is reporting an underlying deficit (excluding STF income) of 1.2m against a planned surplus of 0.3m at the end of July. The Trust is reporting an FSR rating

More information

Trust Board Meeting: Wednesday 13 November 2013 TB

Trust Board Meeting: Wednesday 13 November 2013 TB Trust Board Meeting: Wednesday 13 November 2013 Title Financial Performance to 30 September 2013 Status History For Information This is a regular report. Board Lead(s) Mr Mark Mansfield, Director of Finance

More information

Board Sponsor: Sarah Truelove, Director of Finance and Deputy Chief Executive. Author: Lynne Abbott, Head of Financial Management

Board Sponsor: Sarah Truelove, Director of Finance and Deputy Chief Executive. Author: Lynne Abbott, Head of Financial Management Report To: Public Trust Board Agenda item: 13 Date of Meeting: 23 October 2013 Title of Report: Finance Report Status: Discussion Board Sponsor: Sarah Truelove, Director of Finance and Deputy Chief Executive

More information

2016/17 Financial Performance

2016/17 Financial Performance UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST PAGE 1 OF 2 2016/17 Financial Performance Author: Tarun Basra Sponsor: Paul Traynor Date: Trust Board Meeting 4 th May 2017 Executive Summary Trust Board paper

More information

BOARD OF DIRECTORS COVER SHEET PART 1. DATE: 30 January Subject: CHARITABLE FUNDS EXPENDITURE OVER 25,000

BOARD OF DIRECTORS COVER SHEET PART 1. DATE: 30 January Subject: CHARITABLE FUNDS EXPENDITURE OVER 25,000 BOARD OF DIRECTORS COVER SHEET PART 1 DATE: 3 January 219 Agenda item: 11 Paper: F Subject: CHARITABLE FUNDS EXPENDITURE OVER 25, Prepared by: Presented by: Purpose of paper Background Key points for Board

More information

For Assurance x For decision For discussion To note

For Assurance x For decision For discussion To note Item 8 Report to Board 7September 2017 Report title Monthly financial performance for month 4 July 2017 Report from Prepared by Previously discussed at Attachments Steven Davies, Chief Financial Officer/Deputy

More information

Board of Directors Meeting Report 25 May Agenda item 49/16

Board of Directors Meeting Report 25 May Agenda item 49/16 Board of Directors Meeting Report 25 May 2016 Agenda item 49/16 Title Sponsoring Director Author(s) Financial Position James O Sullivan Chief Financial Officer Adrian Buggle Deputy Director of Finance

More information

The Royal Wolverhampton NHS Trust

The Royal Wolverhampton NHS Trust The Royal Wolverhampton NHS Trust Trust Board Meeting Date: 25 April 2016 Title: Income and Expenditure Plan for 2016/17 Executive Summary: Action Requested: This report details the proposed Income & Expenditure

More information

Month 10 Finance Report

Month 10 Finance Report TAUNTON & SOMERSET NHS FOUNDATION TRUST Month 10 Finance Report Report to: Trust Board on 24 February 2016 Purpose of the Report: The purpose of the report is to update the Board on the Month 10 financial

More information

Item 6. Monthly Finance Report For November Prepared by: Stephen Dunham Financial Controller

Item 6. Monthly Finance Report For November Prepared by: Stephen Dunham Financial Controller 1 Item 6 Monthly Finance Report For November 2015 Prepared by: Stephen Dunham Financial Controller Helen De Spretter Head of Financial Performance and Decision Making David Bebb Deputy Finance Director

More information

Corporate Performance Report 2015/16

Corporate Performance Report 2015/16 Bod/76/15 Corporate Performance Report 2015/16 May 2015 OUR VISION: OUR MISSION: To be known as one of the top ten hospital Trusts in England and the Kent hospital of choice for patients and those close

More information

Integrated Quality, Performance and Finance Reporting Framework. Reporting period: Month 9 December 2014

Integrated Quality, Performance and Finance Reporting Framework. Reporting period: Month 9 December 2014 Integrated Quality, Performance and Finance Reporting Framework Reporting period: Month 9 December 2014 Contents Section Page Trust Scorecard 3 Trust Heatmap 5 Scorecard matrix 6 Areas of underperformance

More information

Finance Assurance Report. February 2017

Finance Assurance Report. February 2017 Finance Assurance Report February 2017 1 Executive summary Key Financial Information I&E Year to Date Full year Cash flow Year to Date Full year Budget Actual Variance Budget Plan Actual Variance Plan

More information

Jason Dorsett, Chief Finance Officer

Jason Dorsett, Chief Finance Officer Trust Board Meeting in Public: Wednesday 11th July 2018 Title Financial Performance to 31 May 2018 Status Regular Report History Board Lead Jason Dorsett, Chief Finance Officer Key purpose Strategy Assurance

More information

Finance Assurance Report. March 2017

Finance Assurance Report. March 2017 Finance Assurance Report March 2017 1 Executive summary Key Financial Information I&E Year to Date Budget Actual Variance m m m Income 176.8 180.2 3.4 Pay -137.6-137.1 0.5 Non pay -36.6-38.8-2.2 Unallocataed

More information

Corporate Performance Report 2013/14

Corporate Performance Report 2013/14 BoD/04/14 Corporate Performance Report 2013/14 December 2013 OUR VISION: OUR MISSION: To be known as one of the top ten hospital Trusts in England and the Kent hospital of choice for patients and those

More information

Trust Board Meeting: Wednesday 8 July 2015 TB Title Financial Performance to 31 May 2015

Trust Board Meeting: Wednesday 8 July 2015 TB Title Financial Performance to 31 May 2015 Trust Board Meeting: Wednesday 8 July 2015 Title Financial Performance to 31 May 2015 Status History A paper for report. Regular report Board Lead Mr Mark Mansfield, Director of Finance and Procurement

More information

BNSSG CCG Governing Body Meeting

BNSSG CCG Governing Body Meeting BNSSG CCG Governing Body Meeting Date: Tuesday 5 th February 2019 Time: 1.30pm Location: The Royal Hotel, 1 South Parade, Weston-super-Mare BS23 1JP Agenda number: 8.2 Report title: BNSSG CCG Finance Report

More information

345,780 Financed by: Taxpayers' Equity 360, , , ,617

345,780 Financed by: Taxpayers' Equity 360, , , ,617 Financial Year Ending 31st March 2015 Agenda Item 11(01) 1.1 - Trust Income & Expenditure Report period ended 31st October 2014 The Trust s reported financial position improved significantly in October,

More information

Finance Performance Report

Finance Performance Report Finance Finance Performance Report October 217 For the period April to October 217-18 Southend University Hospital Foundation Trust Board 7 INDEX Page Finance Summary 1 Income 2 Activity 3 Pay 4 Pay analysis

More information

MERTON CLINICAL COMMISSIONING GROUP GOVERNING BODY

MERTON CLINICAL COMMISSIONING GROUP GOVERNING BODY MERTON CLINICAL COMMISSIONING GROUP GOVERNING BODY Date of Meeting: 30 th November 2017 Agenda No: 9.2 Attachment: 11 Title of Document: Finance Report Month 7 Report Author: Robert Kirton Purpose of Report:

More information

Finance Report, end of November 2015 (month eight)

Finance Report, end of November 2015 (month eight) Agenda item: 8.1a Subject: Presented by: Submitted to: Finance Report, end of November 2015 (month eight) Steve Ham, Chief Finance Officer Governing Body Date: 13 January 2015 Purpose of paper: For information

More information

EXECUTIVE SUMMARY EXECUTIVE SUMMARY

EXECUTIVE SUMMARY EXECUTIVE SUMMARY EXECUTIVE SUMMARY EXECUTIVE SUMMARY Report to Trust Board Date Tuesday 23 September 2014 Agenda Number 3.1 Agenda Item Finance Report August 2014 Sponsor Andy Robinson, Director of Finance & Performance

More information

Report to: Public Trust Board Agenda item: 2.2 Date of Meeting: 12 May 2010

Report to: Public Trust Board Agenda item: 2.2 Date of Meeting: 12 May 2010 Report to: Public Trust Board Agenda item: 2.2 Date of Meeting: 12 May 2010 Title of Report: Status: Board Sponsor: Author: Appendices 1 2 3 4 5 6 7 Finance report Discussion Catherine Phillips, Director

More information

Trust Board Meeting 24th February 2011 FINANCE REPORT for the period ending 31st January 2011 (Month 10)

Trust Board Meeting 24th February 2011 FINANCE REPORT for the period ending 31st January 2011 (Month 10) Trust Board Meeting 24th February 2011 FINANCE REPORT for the period ending 31st January 2011 (Month 10) Enclosure 8 EXECUTIVE RESPONSIBILE AUTHOR (if different from above) CORPORATE OBJECTIVE EXECUTIVE

More information

The Royal Wolverhampton NHS Trust

The Royal Wolverhampton NHS Trust The Royal Wolverhampton NHS Trust Trust Board Report Meeting Date: 30 th March 2015 Title: Income and Expenditure Plan for 2015/16 Executive Summary: Action Requested: Report of: Author: Contact Details:

More information

Integrated Performance Report M Executive Summary

Integrated Performance Report M Executive Summary M1 2017-2018 Executive Summary Risk ratings Financial Use of Resources Rating: 17/18 Plan: YTD FY Performance: YTD 2 2 Current 3 Previous Mth Summary Performance: The Trust has recorded a YTD loss of 5.2M,

More information

UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST. Finance Report. Paul Goddard, Assistant Director of Finance

UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST. Finance Report. Paul Goddard, Assistant Director of Finance UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST Finance Report Report to: Trust Board 29 th November 2011 Report from: Sponsoring Executive: Purpose of Report: Review History to Date: Recommendation:

More information

Clive Field, Interim Director of Finance and Performance. 20 June 2016

Clive Field, Interim Director of Finance and Performance. 20 June 2016 Clive Field, Interim Director of Finance and Performance 20 June 2016 Summary I & E Position The Trust is forecasting 1.1m before impairments in line with the plan. The plan includes 0.2m impairment which

More information

2015/16 Financial Position (Month 2) Author: Lorraine Bentley Sponsor: Paul Traynor Date: Trust Board - Thursday 2 nd July 2015

2015/16 Financial Position (Month 2) Author: Lorraine Bentley Sponsor: Paul Traynor Date: Trust Board - Thursday 2 nd July 2015 U N I V E R S I T Y H O S P I T A L S O F L E I C E S T E R N H S T R U S T P A G E 1 O F 2 2015/16 Financial Position (Month 2) Author: Lorraine Bentley Sponsor: Paul Traynor Date: Trust Board - Thursday

More information

2015/16 Financial Performance (Month 7) The Trust is planning for a deficit of 34.1m in 2015/16, including delivery of 43m of CIP.

2015/16 Financial Performance (Month 7) The Trust is planning for a deficit of 34.1m in 2015/16, including delivery of 43m of CIP. UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST TRUST BOARD 3 DECEMBER PAGE 1 OF 2 /16 Financial Performance (Month 7) Author: Chris Benham Sponsor: Paul Traynor Trust Board paper N Executive Summary Context

More information

The Royal Wolverhampton NHS Trust

The Royal Wolverhampton NHS Trust The Royal Wolverhampton NHS Trust Finance and Performance Committee Report Meeting Date: Wednesday 21st May 2017 Title: Executive Summary: Finance and Performance Committee Supplementary Finance report

More information

SOMERSET PARTNERSHIP NHS FOUNDATION TRUST FINANCE REPORT. Report to the Trust Board 4 July 2018

SOMERSET PARTNERSHIP NHS FOUNDATION TRUST FINANCE REPORT. Report to the Trust Board 4 July 2018 G SOMERSET PARTNERSHIP NHS FOUNDATION TRUST FINANCE REPORT Report to the Trust Board 4 July 2018 Sponsoring Director: Author: Executive Summary Director of Finance. Director of Finance supported by Deputy

More information

SOUTHPORT & ORMSKIRK HOSPITAL NHS TRUST

SOUTHPORT & ORMSKIRK HOSPITAL NHS TRUST SOUTHPORT & ORMSKIRK HOSPITAL NHS TRUST FINANCE COMMITTEE MEETING 27 th NOVEMBER 2006 DIRECTOR OF FINANCE REPORT FOR THE PERIOD ENDING 31 st OCTOBER 2006 1. FINANCIAL POSITION 1.1 Overview This report

More information

Finance Reporting Pack

Finance Reporting Pack Finance Reporting Pack July 2018 (Month 4) Geoff Price Director of Finance Sutton Clinical Commissioning Group 1 Contents 1 Finance Scorecard 2 Key Indicators 3 Month 4 Financial Position 4 Summary Financial

More information

West Hertfordshire Hospitals NHS Trust. Finance Report. Period 12. April to March 2009

West Hertfordshire Hospitals NHS Trust. Finance Report. Period 12. April to March 2009 West Hertfordshire Hospitals NHS Trust Finance Report Period 12 April to March 2009 Presented by Phil Bradley (Acting) Director of Finance 17 April 2009 1 Summary Financial Overview as at 31 March 2009

More information

2015/16 Financial Position to Month 1 - April. Author: [Lorraine Bentley] Sponsor: [Paul Traynor] Date: [Thursday 4 June 2015]

2015/16 Financial Position to Month 1 - April. Author: [Lorraine Bentley] Sponsor: [Paul Traynor] Date: [Thursday 4 June 2015] U N I V E R S I T Y H O S P I T A L S O F L E I C E S T E R N H S T R U S T P A G E 1 O F 2 2015/16 Financial Position to Month 1 - April Author: [Lorraine Bentley] Sponsor: [Paul Traynor] Date: [Thursday

More information

EXECUTIVE SUMMARY. REPORT TO: Trust Board DATE: Thursday 3 January 2019 AGENDA NO: 3.1 AGENDA ITEM: Financial Report November 2018 SPONSOR:

EXECUTIVE SUMMARY. REPORT TO: Trust Board DATE: Thursday 3 January 2019 AGENDA NO: 3.1 AGENDA ITEM: Financial Report November 2018 SPONSOR: EXECUTIVE SUMMARY REPORT TO: Trust Board DATE: Thursday 3 January 2019 AGENDA NO: 3.1 AGENDA ITEM: Financial Report November 2018 SPONSOR: Angela Hibbard, Director of Finance PREPARED BY: Colin Dart, Deputy

More information

2017/18 Financial Performance

2017/18 Financial Performance UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST TRUST BOARD 1 JUNE 217 PAGE 1 OF 2 217/18 Financial Performance Author: Lisa Gale Sponsor: Paul Traynor Trust Board paper P Executive Summary Context The Trust

More information

29th September Spencer Prosser, Chief Financial Officer. Bill Stronach, Deputy Chief Financial Officer. Finance Report Month /17

29th September Spencer Prosser, Chief Financial Officer. Bill Stronach, Deputy Chief Financial Officer. Finance Report Month /17 Meeting: Date: Board Sponsor: Paper Author: Subject: Brighton and Sussex University Hospitals NHS Trust Board of Directors 29th September 2016 Spencer Prosser, Chief Financial Officer Bill Stronach, Deputy

More information

Paper Finance Report. Month 9 (December 2015)

Paper Finance Report. Month 9 (December 2015) Paper 16.0 Finance Report Month 9 (December 2015) Finance Report Month 9 (December 2015) Index Slide Executive Summary 2 Summary Financial Position 3 Key Variances 5 Reserves 7 Risks and Opportunities

More information

Review of Cumulative Performance against Service Level Agreements September 2008

Review of Cumulative Performance against Service Level Agreements September 2008 ATTACHMENT 2 Review of Cumulative Performance against Service Level Agreements September 2008 1. Executive Summary 1.1 This paper provides a review of the Trust s delivery against commissioned levels of

More information

SOUTHAMPTON UNIVERSITY HOSPITALS NHS TRUST. Corporate Monitoring Report. Alastair Matthews, Director of Finance

SOUTHAMPTON UNIVERSITY HOSPITALS NHS TRUST. Corporate Monitoring Report. Alastair Matthews, Director of Finance SOUTHAMPTON UNIVERSITY HOSPITALS NHS TRUST Report to: Trust Board 1 st July 2008 Corporate Monitoring Report Report from Sponsoring Executive: Purpose of Report: Review History to Date: Recommendation:

More information

TRUST BOARD PART I OCTOBER 2011 Agenda Item Number: 161/11 Enclosure Number: (3) Finance Report. Regular reporting. For information/awareness

TRUST BOARD PART I OCTOBER 2011 Agenda Item Number: 161/11 Enclosure Number: (3) Finance Report. Regular reporting. For information/awareness TRUST BOARD PART I OCTOBER 2011 Agenda Item Number: 161/11 Enclosure Number: (3) Subject Prepared by: Sponsored by: Presented by: Finance Report Steve Gooch, Deputy Director of Finance Robert D Toole.

More information

Agenda Item 6.4 CCG Board EXECUTIVE SUMMARY SHEET

Agenda Item 6.4 CCG Board EXECUTIVE SUMMARY SHEET Agenda Item 6.4 CCG Board EXECUTIVE SUMMARY SHEET DATE: 9 th August 2016 TITLE OF PAPER: Financial Position- Month 3 EXECUTIVE RESPONSIBLE: Laura Boden - Acting Chief Finance Officer Ext:2483 Email: lboden@nhs.net

More information

Report to the Merton Clinical Commissioning Group Governing Body

Report to the Merton Clinical Commissioning Group Governing Body MCCG Bd 24.01.13 Pt1 :6.1 : Att 03 Merton Clinical Commissioning Group Report to the Merton Clinical Commissioning Group Governing Body Date of Meeting: Thursday 24 th January 2013 Agenda No: 6.1 ATTACHMENT

More information

This report provides headlines of the finance and contracting position for the 12 months ended 31st March 2017.

This report provides headlines of the finance and contracting position for the 12 months ended 31st March 2017. Finance & Contracting Performance Report: Period ended 31 March 2017 Introduction This report provides headlines of the finance and contracting position for the 12 months ended 31st March 2017. 1 Revenue

More information

Vicki Taylor, Deputy Chief Finance Officer. Vicki Taylor 16/03/2018. No Commissioning, Finance and Performance Committee

Vicki Taylor, Deputy Chief Finance Officer. Vicki Taylor 16/03/2018. No Commissioning, Finance and Performance Committee Agenda item: 3.6 Paper No: 11 Committee: Governing Body Venue: Board Room, Dominion House, Guildford Date: 27/03/2018 Status: FOR REVIEW AND NOTE Title of Report Presented by Author Finance Lead sign off

More information

SOMERSET PARTNERSHIP NHS FOUNDATION TRUST FINANCE REPORT. Report to the Trust Board 8 May 2018

SOMERSET PARTNERSHIP NHS FOUNDATION TRUST FINANCE REPORT. Report to the Trust Board 8 May 2018 F SOMERSET PARTNERSHIP NHS FOUNDATION TRUST FINANCE REPORT Report to the Trust Board 8 May 2018 Sponsoring Director: Author: Purpose of the report: Key Issues and Recommendations: Director of Finance.

More information

Take control of your business performance

Take control of your business performance Take control of your business performance 16 October 2017 Presented by: Johan Nel Group Financial Manager Cure Day Clinics Knowledge Doubling Curve Introduction Buckminster Fuller created the Knowledge

More information

Report. Chris Ford Joint Chief Finance Officer

Report. Chris Ford Joint Chief Finance Officer Governing Body Meeting held in public Report Date of Meeting: 8 November 2018 Agenda Item: 15.0 Report Title Finance Report as at 30 th September 2018 (Month 6) Report Author Presented By Responsible Director

More information

3 February 2016 Enclosure H1

3 February 2016 Enclosure H1 Report to Trust Board (in public) Title Finance & Performance Committee Chairman Report Sponsoring Director F & P Committee Chairman / Non-Executive Director Author Haq Khan Deputy Director of Finance

More information

CORPORATE PERFORMANCE DASHBOARD. August 2010

CORPORATE PERFORMANCE DASHBOARD. August 2010 Quality care for you, with you CORPORATE PERFORMANCE DASHBOARD August 21 Approved by the Board of Directors on 3 th September 21 1 CONTENT: Page Introduction 3 Targets: 1 st OP Appointment 4 Diagnostic

More information

Catherine Phillips, Director of Finance Sarah Elsey, Interim Head of Financial Management

Catherine Phillips, Director of Finance Sarah Elsey, Interim Head of Financial Management Report To: Public Trust Board Agenda item: 11 Date of Meeting: 26 September 2012 Title of Report: Status: Board Sponsor: Author: Appendices Report Discussion Catherine Phillips, Director of Sarah Elsey,

More information

MANCHESTER UNIVERSITY NHS FOUNDATION TRUST BOARD OF DIRECTORS

MANCHESTER UNIVERSITY NHS FOUNDATION TRUST BOARD OF DIRECTORS MANCHESTER UNIVERSITY NHS FOUNDATION TRUST BOARD OF DIRECTORS Report of: Adrian Roberts Chief Finance Officer Paper prepared by: Adrian Roberts Chief Finance Officer Date of paper: 25 th October 2017 Subject:

More information

KCCG Finance Report September Yarlini Roberts Local Director of Finance

KCCG Finance Report September Yarlini Roberts Local Director of Finance KCCG Finance Report September 2017 Yarlini Roberts Local Director of Finance Produced by Finance September 2017 1 Contents 1. Finance Scorecard 2. Key Indicators 3. Summary Financial Position 4. Run Rate

More information

The 2014/15 year to date (YTD) revenue position for GYW CCG is 1,565k surplus which is to plan.

The 2014/15 year to date (YTD) revenue position for GYW CCG is 1,565k surplus which is to plan. Governing Body Meeting 27 November 2014 Agenda Item 17 Title of paper What the Committee is being asked to decide or approve Great Yarmouth & Waveney Clinical Commissioning Group Finance & QIPP Report

More information

Forecast Position. Detailed financial statements are included in the Appendix attached to this report.

Forecast Position. Detailed financial statements are included in the Appendix attached to this report. MEMO To: Board Members From: Eric Sinclair, GM Finance & Performance Date: 17 January 2018 Subject: Financial Report for December 2017 Status This report contains: For decision Update Regular report For

More information

NHS BOLTON CLINICAL COMMISSIONING GROUP Public Board Meeting AGENDA ITEM NO: 9. Date of Meeting: 27 th February CCG Corporate Performance Report

NHS BOLTON CLINICAL COMMISSIONING GROUP Public Board Meeting AGENDA ITEM NO: 9. Date of Meeting: 27 th February CCG Corporate Performance Report NHS BOLTON CLINICAL COMMISSIONING GROUP Public Board Meeting AGENDA ITEM NO: 9 Date of Meeting: 27 th February 2015 TITLE OF REPORT: AUTHOR: PRESENTED BY: PURPOSE OF PAPER: (Linking to Strategic Objectives)

More information

Governing Body Meeting in Public

Governing Body Meeting in Public Agenda Item No: Item 7 of Meeting: Thursday 30 th March 2017 Governing Body Meeting in Public Paper Title: Finance Report Month 10 2016/17 Decision Discussion Information Follow up from last meeting Report

More information

Paper Finance Report. Month 11 (February 2016)

Paper Finance Report. Month 11 (February 2016) Paper 12.0 Finance Report Month 11 (February 2016) Finance Report Month 11 (February 2016) Index Slide Executive Summary 2 Summary Financial Position 3 Key Variances 5 Reserves 7 Risks and Opportunities

More information

Operational Performance. SaTH Overall Performance

Operational Performance. SaTH Overall Performance Balanced Scorecard Summary Operational Performance Previous This Year to Date Previous This Year to Date Number Number Number Number Number Green 17 17 15 Green 7 7 0 Amber 3 2 2 Amber 1 0 0 Red 2 4 5

More information

Board s corporate objectives for outline a requirement to provide best value for resources and deliver financial balance.

Board s corporate objectives for outline a requirement to provide best value for resources and deliver financial balance. Board Paper 2017/12 Shetland NHS Board Meeting: Shetland NHS Board Date: 18 April 2017 Paper Title: Finance monitoring report (2016-17) to 28 February 2017 Author: Colin Marsland Job Title: Director of

More information

Board s corporate objectives for outline a requirement to provide best value for resources and deliver financial balance.

Board s corporate objectives for outline a requirement to provide best value for resources and deliver financial balance. Board Paper 2017/04 Shetland NHS Board Meeting: Shetland NHS Board Date: 14 February 2017 Paper Title: Finance monitoring report (2016-17) to 31 December 2016 Author: Colin Marsland Job Title: Director

More information

BOARD OF DIRECTORS Meeting Date: Thursday, 28 January 2010

BOARD OF DIRECTORS Meeting Date: Thursday, 28 January 2010 Serving the people of North East Essex BOARD OF DIRECTORS Meeting Date: Thursday, 28 January 2010 Agenda Item: 14 (Disclosable) Title: Performance and Risk Assurance Report: Month 9 Purpose: Summary: Chief

More information

Chief Finance Officer. The CCG reports a surplus of 79k for the year after holding a projected a surplus of 32k for the last three months.

Chief Finance Officer. The CCG reports a surplus of 79k for the year after holding a projected a surplus of 32k for the last three months. Agenda item 8 TITLE PRESENTED BY LEAD MANAGER PURPOSE OF PAPER RECOMMENDATION EQUALITY & DIVERSITY IMPACT FINANCE REPORT Stephen Schofield Chief Finance Officer Stephen Schofield Chief Finance Officer

More information

SALISBURY NHS FOUNDATION TRUST

SALISBURY NHS FOUNDATION TRUST SALISBURY NHS FOUNDATION TRUST PAPER NUMBER: SFT 3001 TITLE: FINANCE REPORT FOR THE PERIOD TO 30 APRIL 2010 PURPOSE OF PAPER: To inform the Board of the financial and contracting position to 30 April 2010.

More information

Report. Date of Meeting: 6 th September 2018

Report. Date of Meeting: 6 th September 2018 Governing Body Meeting held in Public Report Date of Meeting: 6 th September 2018 Agenda Item: 11.0 Report Title Finance Report as at 31 st July 2018 (Month 4) Report Author Presented By Responsible Director

More information

0.1% > variance < 0.5% 0.1% > variance < 0.5% <95% but >= 50% of plan

0.1% > variance < 0.5% 0.1% > variance < 0.5% <95% but >= 50% of plan Commentary Template The commentary template will need to be completed when either; a) An organisation is red rated in any of the criteria set out below Indicator Green Amber Red Comments Surplus -(variance

More information

GOVERNING BODY FINANCE REPORT MONTH 9

GOVERNING BODY FINANCE REPORT MONTH 9 LEAD: Neil Ferrelly, Chief Finance Officer REPORT AUTHOR: Jenny Sinnott, Head of Finance GOVERNING BODY ATTACHMENT: AGENDA ITEM: 9 H RECOMMENDATION: The Governing Body is asked to note the points raised

More information

Item: 5.1. REPORT TO THE PUBLIC TRUST BOARD MEETING 30 th May Executive Summary. Title

Item: 5.1. REPORT TO THE PUBLIC TRUST BOARD MEETING 30 th May Executive Summary. Title REPORT TO THE PUBLIC TRUST BOARD MEETING 30 th May 2013 Item: 5.1 Title Lead Director Author(s) Purpose Previously considered by Executive Summary Integrated Performance Report Mary Leadbeater - Interim

More information

Agenda Item 7 Date: 30 November Rob Forster, Director of Finance & IM&T. Approve Adopt Receive for information

Agenda Item 7 Date: 30 November Rob Forster, Director of Finance & IM&T. Approve Adopt Receive for information Trust Board Agenda Item 7 Date: 30 November 20 Title of Report Finance Board Report Month 7 Purpose of the report and the key issues for consideration/decision To update Trust Board on the monthly financial

More information

Board/Committee Prompts Does the Board require any additional information reported in future papers?

Board/Committee Prompts Does the Board require any additional information reported in future papers? EXECUTIVE SUMMARY REPORT TO: Trust Board DATE: Tuesday 5 December 2017 AGENDA NO: 3.1 AGENDA ITEM: SPONSOR: Colin Dart, Acting PREPARED BY: Colin Dart, Acting PRESENTED BY: Colin Dart, Acting Purpose The

More information

CCG FINANCE MONTHLY REPORT GUIDE January 2014

CCG FINANCE MONTHLY REPORT GUIDE January 2014 CCG FINANCE MONTHLY REPORT GUIDE January 2014 Contents Page INTRODUCTION 3 Example CCG Finance report 4 1. ACUTE COMMISSIONING 6 Payment by Results (PBR) 6 Market Forces Factor (MFF) 7 Contract Adjustments

More information

2017/18 Financial Plan and Budgets. John Ingham, Chief Finance Officer, NHS Norwich CCG. Discussion and Approval

2017/18 Financial Plan and Budgets. John Ingham, Chief Finance Officer, NHS Norwich CCG. Discussion and Approval Agenda Item: 13 NHS Norwich CCG Governing Body Tuesday 28 th March 2017 Subject: Presented By: 2017/18 Financial Plan and Budgets John Ingham, Chief Finance Officer, NHS Norwich CCG Submitted To: NHS Norwich

More information

NHS LANARKSHIRE FINANCE REPORT FOR THE YEAR ENDED 31 MARCH 2006

NHS LANARKSHIRE FINANCE REPORT FOR THE YEAR ENDED 31 MARCH 2006 NHS LANARKSHIRE FINANCE REPORT FOR THE YEAR ENDED 31 MARCH 2006 1. Purpose of Report The purpose of this report is to provide the NHS Board with the summary financial position for the year ended 31 March

More information

SOUTHPORT & ORMSKIRK HOSPITAL NHS Trust

SOUTHPORT & ORMSKIRK HOSPITAL NHS Trust SOUTHPORT & ORMSKIRK HOSPITAL NHS Trust FINANCE COMMITTEE MEETING 30 TH JANUARY 2006 DIRECTOR OF FINANCE REPORT FOR THE PERIOD ENDING 31st DECEMBER 2005 1. FINANCIAL POSITION 1.1 Overview The Trust s deficit

More information

Appendix 4.1 MEETING: Haringey Clinical Commissioning Group Governing Body Meeting DATE: Thursday, 15 March 2018 TITLE: LEAD DIRECTOR: AUTHOR: CONTACT DETAILS: Operating Plan: Timetable and Governance

More information

healthcare; 6. To play an active and influential role in shaping SE London and London wide X commissioning.

healthcare; 6. To play an active and influential role in shaping SE London and London wide X commissioning. GOVERNING BODY Title of paper: Finance Update Month 4 Date of meeting: 5 th September 2018 Presented by: David Maloney Title: Chief Finance Officer & email contact: D.Maloney@nhs.net Prepared by: Nick

More information

Finance Report March 2012

Finance Report March 2012 INTRODUCTION 1. This report presents the financial results for the eleven month period to 29 th February 2012 and the projected outturn for 2011/12. FINANCIAL OUTLOOK 2011/12 2. The forecast outturn assumes

More information

Agenda Item 7.3 CCG BOARD EXECUTIVE SUMMARY SHEET

Agenda Item 7.3 CCG BOARD EXECUTIVE SUMMARY SHEET Agenda Item 7.3 CCG BOARD EXECUTIVE SUMMARY SHEET DATE: 8 th March 2016 TITLE OF PAPER: Financial Position- Month 10 EXECUTIVE RESPONSIBLE: Andrew Tannatt Nash - Chief Finance Officer Ext:2338 Email: andrew.nash@telfordccg.nhs.uk

More information

Agenda Item 9.1. Meeting / Committee. Meeting Date. 25 September Board of Directors. Information. This paper is for

Agenda Item 9.1. Meeting / Committee. Meeting Date. 25 September Board of Directors. Information. This paper is for Agenda Item 9.1 Meeting / Committee Board of Directors Meeting Date 25 September 2012 This paper is for Action/Decision Assurance X Information Title Financial position for the period ending 31 August

More information

INTRODUCTION TO NHS FINANCES. Paul Betts, Economic Adviser, FTN

INTRODUCTION TO NHS FINANCES. Paul Betts, Economic Adviser, FTN INTRODUCTION TO NHS FINANCES Paul Betts, Economic Adviser, FTN How the money flows in the NHS Parliament raises taxes and National insurance Political Decision The Treasury National Commissioning Board

More information

Attachment D1. Month 6 QIPP Report. 1 Background

Attachment D1. Month 6 QIPP Report. 1 Background Attachment D1 Month 6 QIPP Report 1 Background 1.1 The South West London (SWL) Quality, Innovation, Productivity and Prevention (QIPP) plans are set in a context of an environment in which complex issues

More information

Forecast Position. Detailed financial statements are included in the Appendix attached to this report. March 2018 $Ms Year to Date $Ms Full Year $Ms

Forecast Position. Detailed financial statements are included in the Appendix attached to this report. March 2018 $Ms Year to Date $Ms Full Year $Ms MEMO To: Board Members From: Eric Sinclair, GM Finance & Performance Date: 18 April 2018 Subject: Financial Report for February 2018 Status This report contains: For decision Update Regular report For

More information

To: Trust Board From: Abi Tierney Director of Strategy Andrew Seddon Director of Finance & Procurement Date: 4 th February 2010 Healthcare standard:

To: Trust Board From: Abi Tierney Director of Strategy Andrew Seddon Director of Finance & Procurement Date: 4 th February 2010 Healthcare standard: Paper C To: Trust Board From: Abi Tierney Director of Strategy Andrew Seddon Director of Finance & Procurement Date: 4 th February 2010 Healthcare standard: C7 a&c Title: Better For Less: Financial Planning

More information

NHS BOARD MEETING 19 NOVEMBER Subject: Purpose: Recommendation:

NHS BOARD MEETING 19 NOVEMBER Subject: Purpose: Recommendation: NHS Board Meeting 19 November 2008 paper 14 NHS BOARD MEETING 19 NOVEMBER 2008 Subject: Purpose: Recommendation: NHS Ayrshire and Arran Financial Management Report for 6 months ended 30 September 2008.

More information

Primary Care Commissioning Committee (PCCC) Finance Paper November 2017

Primary Care Commissioning Committee (PCCC) Finance Paper November 2017 Primary Care Commissioning Committee (PCCC) Finance Paper November 2017 1.1 CCG Finance Update Shown below is a summary of the financial position to 30 th November 2017 of the areas of Primary Care spend

More information

TITLE OF REPORT: QIPP Programme Update Month 7. Kelly Knowles Head of Strategic Financial Planning. Annette Walker Chief Finance Officer

TITLE OF REPORT: QIPP Programme Update Month 7. Kelly Knowles Head of Strategic Financial Planning. Annette Walker Chief Finance Officer NHS BOLTON CLINICAL COMMISSIONING GROUP Public Board Meeting AGENDA ITEM NO: 13 Date of Meeting: 25 th November 2016 TITLE OF REPORT: QIPP Programme Update Month 7 AUTHOR: PRESENTED BY: PURPOSE OF PAPER:

More information

Board of Directors Finance Presentation 2015/16. Friday 25th September 2015

Board of Directors Finance Presentation 2015/16. Friday 25th September 2015 Board of Directors Finance Presentation 2015/16 Friday 25th September 2015 1. Summary of 2015/16 financial position This presentation is to update the Board in public of our latest financial position.

More information

NHS Wandsworth Finance Report. For the period April 2012 November 2012 & Interim Report up to December 2012

NHS Wandsworth Finance Report. For the period April 2012 November 2012 & Interim Report up to December 2012 NHS Wandsworth Finance Report For the period April 2012 November 2012 & Interim Report up to December 2012 06/02/2013 Produced by Finance 1 Finance Scorecard up to November 2012 Financial Strategy Work

More information

Finance and Performance Committee

Finance and Performance Committee Governing Body 29 th January 2016 Finance Report Agenda Item 9 Paper 4 Author: Executive Lead: Relevant Committees or forums that have already reviewed this paper: Action required: Attached: CCG Strategic

More information

Board s corporate objectives for outline a requirement to provide best value for resources and deliver financial balance.

Board s corporate objectives for outline a requirement to provide best value for resources and deliver financial balance. Board Paper 2016/55 Shetland NHS Board Meeting: Shetland NHS Board Date: 13 December 2016 Paper Title: Finance monitoring report (2016-17) to 31 October 2016 Author: Colin Marsland Job Title: Director

More information

Primary Care Commissioning Committee

Primary Care Commissioning Committee Primary Care Commissioning Committee DETAILS Part 1 (Open) x Part 2 (Closed) Agenda Item 4.1 Meeting Primary Care Commissioning Committee Date 12 October 2017 Title of Paper Finance Report August 2017

More information

INDEPENDENT TRUST FINANCING FACILITY APPLICATION

INDEPENDENT TRUST FINANCING FACILITY APPLICATION INDEPENDENT TRUST FINANCING FACILITY APPLICATION Name of Trust: University Hospital of South Manchester NHS Foundation Trust Loans Proposed 1) 25,000,000 2) 30,000,000 Date of application: 17th January

More information

GOVERNING BODY MEETING held in public 30 September 2015 Agenda Item 2.1

GOVERNING BODY MEETING held in public 30 September 2015 Agenda Item 2.1 GOVERNING BODY MEETING held in public 30 September 2015 Paper Title Finance & Performance Report Month 05, as at 31 August 2015 APPENDIX A Finance & Performance Report, Month 05, as at 31 August 2015 Appendix

More information

OFFICIAL. Date 14 March 2019 COSLA Conference Centre, Edinburgh

OFFICIAL. Date 14 March 2019 COSLA Conference Centre, Edinburgh Agenda Item 10.1 Meeting SPA Resources Committee Date 14 March 2019 Location COSLA Conference Centre, Edinburgh Title of Paper 2018/19 Financial Monitoring Report Presented By Chris Brown, Strategic Financial

More information